ArticleAnnals of clinical and translational neurology2015
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Yen Chih Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it